2022 Precision Oncology Patient Innovation Awards
NOW Open for Worldwide Submissions
Bayer is proud to support the second global Precision Oncology Patient Innovation Awards, aimed at fostering innovation and collaboration to improve access to precision oncology care and tackle inequities for people with cancer around the world.
Bayer is proud to support the second global Precision Oncology Patient Innovation Awards, aimed at fostering innovation and collaboration to improve access to precision oncology care and tackle inequities for people with cancer around the world.
Apply for the Precision Oncology Patient Innovation Awards
Step 1: Download the application Step 2: Submit a proposal Deadline for Applications
2022 POPIA Program Timeline
| Action | Dates |
|---|---|
| Application Form submissions | May 2021 |
| Deadline for Application consideration | July 15, 2021 |
| Review Panel considers and rates eligible submissions | July 2021 |
| Review Panel informs applicants | August 2021 |
| Six applicants invited to develop Full Proposals | August 2021 |
| Deadline for Full Proposals | September 2021 |
| Applicants notified | Early October 2021 |
| Successful applicants announced publicly (Personalized Medicine Awareness Month) |
November 2021 |
- Benefit access to tumor testing to inform patient diagnosis and care
- Benefit access to tumor testing to inform patient diagnosis and care
- Benefit access to tumor testing to inform patient diagnosis and care
